Prescription drug · ANDA
Diltiazem Hydrochloride NDC 33342-523
Diltiazem hydrochloride 240 mg/1 · Capsule, Extended release · Oral · Macleods Pharmaceuticals Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 33342-523-02 | 33342052302 | 6 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (33342-523-02)Marketed from Jun 23, 2023 | |
| 33342-523-07 | 33342052307 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (33342-523-07)Marketed from Jun 23, 2023 | |
| 33342-523-10 | 33342052310 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (33342-523-10)Marketed from Jun 23, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Diltiazem Hydrochloride
- Generic name (nonproprietary)
- diltiazem hydrochloride
- Active ingredients
- Diltiazem hydrochloride — 240 mg/1
- Dosage form
- Capsule, Extended release
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218744
- Marketing start
- Listing expires
- Other FDA classes
- Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)
- Identifiers
- Product ID 33342-523_850566b1-0c8e-42bc-85fa-c8ee710f34baSPL ID 850566b1-0c8e-42bc-85fa-c8ee710f34baSPL set ID 850566b1-0c8e-42bc-85fa-c8ee710f34baRxCUI 830795, 830801, 830837, 830845, 830861UNII OLH94387TEUPC 0333342524102, 0333342522108, 0333342523105, 0333342522078, 0333342523075, 0333342521071, 0333342525079, 0333342521101, 0333342525109, 0333342524072
- Pharmacologic class
- Calcium Channel Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N433342052302followed by a unit qualifier and the quantityPackage 33342-0523-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Diltiazem hydrochloride extended-release capsules are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive medications. Diltiazem hydrochloride extended-release capsules is indicated for the management of chronic stable angina and angina due to coronary artery spasm.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 218744
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Diltiazem Hydrochloride | Diltiazem hydrochloride 120 mg/1 | Capsule, Extended releaseOral | Macleods Pharmaceuticals Limited | 33342-521 |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 180 mg/1 | Capsule, Extended releaseOral | Macleods Pharmaceuticals Limited | 33342-522 |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 300 mg/1 | Capsule, Extended releaseOral | Macleods Pharmaceuticals Limited | 33342-524 |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 360 mg/1 | Capsule, Extended releaseOral | Macleods Pharmaceuticals Limited | 33342-525 |